Kathleen Poston, MD, MS

Publications

• Functional brain networks and abnormal connectivity in the movement disorders
  Poston, K. L., & Eidelberg, D. (2012). Functional brain networks and abnormal connectivity in the movement disorders. NEUROIMAGE, 62(4), 2261-2270.
• Network correlates of disease severity in multiple system atrophy
  Poston, K. L., Tang, C. C., Eckert, T., Dhawan, V., Frucht, S., & Eidelberg, D. (2012). Network correlates of disease severity in multiple system atrophy. NEUROLOGY, 78(16), 1237-1244.
• AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
  LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., & Feigin, A. (2011). AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. LANCET NEUROLOGY, 10(4), 309-319.
• Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis Tang, C. C., Poston, K. L., Eckert, T., Feigin, A., Frucht, S., & Eidelberg, D. (2010). Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. LANCET NEUROLOGY, 9(2), 149-158.
  
• Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease Tang, C. C., Poston, K. L., Dhawan, V., & Eidelberg, D. (2010). Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease. JOURNAL OF NEUROSCIENCE, 30(3), 1049-1056.
  
• Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease Mueller-Oehring, E. M., Sullivan, E. V., Pfefferbaum, A., Huang, N. C., Poston, K. L., & Schulte, T. (2015). Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease. BRAIN IMAGING AND BEHAVIOR, 9(3), 619-638.
  
• Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial Olanow, C. W., Bartus, R. T., Baumann, T. L., Factor, S., Boulis, N., & Lang, A. E. (2015). Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. ANNALS OF NEUROLOGY, 78(2), 248-257.
  
• A disease-specific metabolic brain network associated with corticobasal degeneration Niethammer, M., Tang, C. C., Feigin, A., Allen, P. J., Heinen, L., & Eidelberg, D. (2014). A disease-specific metabolic brain network associated with corticobasal degeneration. BRAIN, 137, 3036-3046.
  
• Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) with Myoclonus Poston, K. L., McGovern, R. A., Goldman, J. S., Caccappolo, E., & Mazzoni, P. (2010). Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) with Myoclonus. MOVEMENT DISORDERS, 25(4), 514-516.
  
• FDG PET in the Evaluation of Parkinson's Disease. Poston, K. L., & Eidelberg, D. (2010). FDG PET in the Evaluation of Parkinson's Disease. PET clinics, 5(1), 55-64.
  
• Action tremor of the legs in essential tremor: Prevalence, clinical correlates, and comparison with age-matched controls Poston, K. L., Rios, E., & Louis, E. D. (2009). Action tremor of the legs in essential tremor: Prevalence, clinical correlates, and comparison with age-matched controls. PARKINSONISM & RELATED DISORDERS, 15(8), 602-605.
  
• Network biomarkers for the diagnosis and treatment of movement disorders Poston, K. L., & Eidelberg, D. (2009). Network biomarkers for the diagnosis and treatment of movement disorders. NEUROBIOLOGY OF DISEASE, 35(2), 141-147.
  
• Movement disorder emergencies Poston, K. L., & Frucht, S. J. (2008). Movement disorder emergencies. JOURNAL OF NEUROLOGY, 255, 2-13.
  
• Zydis selegilline in the management of Parkinson's disease Poston, K. L., & Waters, C. (2007). Zydis selegilline in the management of Parkinson's disease. EXPERT OPINION ON PHARMACOTHERAPY, 8(15), 2615-2624.